Symbol:
Arid2
Name:
AT-rich interaction domain 2
RGD ID:
1311105
Description:
Predicted to enable DNA binding activity. Predicted to be involved in several processes, including negative regulation of cell migration; nucleosome disassembly; and positive regulation of double-strand break repair via homologous recombination. Predicted to act upstream of or within embryonic organ development; heart development; and homeostatic process. Predicted to be located in nucleoplasm and plasma membrane. Predicted to be part of SWI/SNF complex and brahma complex. Human ortholog(s) of this gene implicated in Coffin-Siris syndrome 6; colorectal cancer; and hepatocellular carcinoma. Orthologous to human ARID2 (AT-rich interaction domain 2); PARTICIPATES IN SWI/SNF family mediated chromatin remodeling pathway; INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
AT rich interactive domain 2 (Arid-rfx like); AT-rich interactive domain-containing protein 2; LOC366980
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
ARID2 (AT-rich interaction domain 2)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Arid2 (AT-rich interaction domain 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Arid2 (AT-rich interaction domain 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
ARID2 (AT-rich interaction domain 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
ARID2 (AT-rich interaction domain 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Arid2 (AT-rich interaction domain 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
ARID2 (AT-rich interaction domain 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
ARID2 (AT-rich interaction domain 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Arid2 (AT-rich interaction domain 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
ARID2 (AT-rich interaction domain 2)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Arid2 (AT-rich interaction domain 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
arid2 (AT rich interactive domain 2 (ARID, RFX-like))
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Bap170
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
swsn-7
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
pcdh7
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
arid2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 129,326,371 - 129,443,813 (+) NCBI GRCr8 mRatBN7.2 7 127,447,192 - 127,565,987 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 127,447,278 - 127,563,512 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 7 137,680,564 - 137,798,329 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 137,680,530 - 137,795,655 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 137,312,585 - 137,430,353 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 134,959,992 - 135,077,477 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 135,036,399 - 135,153,718 (+) NCBI Celera 7 123,951,414 - 124,071,020 (+) NCBI Celera Cytogenetic Map 7 q35 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Arid2 Rat (-)-demecolcine increases expression ISO RGD:1322383 6480464 Demecolcine results in increased expression of ARID2 mRNA CTD PMID:23649840 Arid2 Rat 1,2-dichloroethane increases expression ISO RGD:1322384 6480464 ethylene dichloride results in increased expression of ARID2 mRNA CTD PMID:28960355 Arid2 Rat 1,2-dimethylhydrazine decreases expression ISO RGD:1322384 6480464 1,2-Dimethylhydrazine results in decreased expression of ARID2 mRNA CTD PMID:22206623 Arid2 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ARID2 mRNA CTD PMID:32145629 Arid2 Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1322384 6480464 2,3',4,4',5-pentachlorobiphenyl results in increased expression of ARID2 mRNA CTD PMID:31388691 Arid2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1322384 6480464 [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in increased expression of ARID2 mRNA CTD PMID:19465110 Arid2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARID2 mRNA CTD PMID:33387578 Arid2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ARID2 mRNA CTD PMID:32109520 Arid2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1322384 6480464 Tetrachlorodibenzodioxin affects the expression of ARID2 mRNA CTD PMID:21570461 Arid2 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2,4-dinitrotoluene affects the expression of ARID2 mRNA CTD PMID:21346803 Arid2 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2,6-dinitrotoluene affects the expression of ARID2 mRNA CTD PMID:21346803 Arid2 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1322383 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Arid2 Rat 4,4'-sulfonyldiphenol decreases expression ISO RGD:1322384 6480464 bisphenol S results in decreased expression of ARID2 mRNA CTD PMID:39298647 Arid2 Rat 4,4'-sulfonyldiphenol affects methylation ISO RGD:1322384 6480464 bisphenol S affects the methylation of ARID2 gene CTD PMID:31683443 Arid2 Rat acetazolamide increases expression ISO RGD:1322384 6480464 Acetazolamide results in increased expression of ARID2 mRNA CTD PMID:19274763 Arid2 Rat aflatoxin B1 decreases methylation ISO RGD:1322383 6480464 Aflatoxin B1 results in decreased methylation of ARID2 gene CTD PMID:27153756 Arid2 Rat aflatoxin B1 increases methylation ISO RGD:1322383 6480464 Aflatoxin B1 results in increased methylation of ARID2 intron CTD PMID:30157460 Arid2 Rat Aflatoxin B2 alpha affects methylation ISO RGD:1322383 6480464 aflatoxin B2 affects the methylation of ARID2 intron CTD PMID:30157460 Arid2 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of ARID2 mRNA CTD PMID:30779732 Arid2 Rat aristolochic acid A decreases expression ISO RGD:1322383 6480464 aristolochic acid I results in decreased expression of ARID2 mRNA; aristolochic acid I results in more ... CTD PMID:33212167 Arid2 Rat atrazine decreases expression ISO RGD:1322383 6480464 Atrazine results in decreased expression of ARID2 mRNA CTD PMID:22378314 Arid2 Rat benzene increases expression ISO RGD:1322383 6480464 Benzene results in increased expression of ARID2 mRNA CTD PMID:19162166 Arid2 Rat benzo[a]pyrene increases mutagenesis ISO RGD:1322383 6480464 Benzo(a)pyrene results in increased mutagenesis of ARID2 gene CTD PMID:25435355 Arid2 Rat benzo[a]pyrene affects methylation ISO RGD:1322383 6480464 Benzo(a)pyrene affects the methylation of ARID2 intron CTD PMID:30157460 Arid2 Rat benzo[a]pyrene decreases methylation ISO RGD:1322384 6480464 Benzo(a)pyrene results in decreased methylation of ARID2 intron CTD PMID:27901495 Arid2 Rat benzo[a]pyrene increases expression ISO RGD:1322384 6480464 Benzo(a)pyrene results in increased expression of ARID2 mRNA CTD PMID:22228805 Arid2 Rat benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1322383 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARID2 mRNA CTD PMID:19150397|PMID:26238291 Arid2 Rat benzo[e]pyrene increases methylation ISO RGD:1322383 6480464 benzo(e)pyrene results in increased methylation of ARID2 intron CTD PMID:30157460 Arid2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ARID2 mRNA CTD PMID:25181051 Arid2 Rat bisphenol A affects methylation ISO RGD:1322383 6480464 bisphenol A affects the methylation of ARID2 promoter CTD PMID:36572933 Arid2 Rat bisphenol A increases methylation ISO RGD:1322383 6480464 bisphenol A results in increased methylation of ARID2 gene CTD PMID:31601247 Arid2 Rat bisphenol A increases expression ISO RGD:1322383 6480464 bisphenol A results in increased expression of ARID2 mRNA CTD PMID:36572933 Arid2 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ARID2 mRNA CTD PMID:32145629 Arid2 Rat bisphenol F multiple interactions ISO RGD:1322383 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Arid2 Rat butanal decreases expression ISO RGD:1322383 6480464 butyraldehyde results in decreased expression of ARID2 mRNA CTD PMID:26079696 Arid2 Rat cadmium dichloride decreases expression ISO RGD:1322384 6480464 Cadmium Chloride results in decreased expression of ARID2 mRNA CTD PMID:24982889 Arid2 Rat caffeine increases phosphorylation ISO RGD:1322383 6480464 Caffeine results in increased phosphorylation of ARID2 protein CTD PMID:35688186 Arid2 Rat carbon nanotube decreases expression ISO RGD:1322384 6480464 Nanotubes, Carbon analog results in decreased expression of ARID2 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681 Arid2 Rat chlordecone increases expression ISO RGD:1322384 6480464 Chlordecone results in increased expression of ARID2 mRNA CTD PMID:33711761 Arid2 Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of ARID2 mRNA CTD PMID:23125180 Arid2 Rat chlorpyrifos decreases expression ISO RGD:1322384 6480464 Chlorpyrifos results in decreased expression of ARID2 mRNA CTD PMID:37019170 Arid2 Rat cisplatin decreases expression ISO RGD:1322383 6480464 Cisplatin results in decreased expression of ARID2 mRNA CTD PMID:27594783 Arid2 Rat clobetasol decreases expression ISO RGD:1322384 6480464 Clobetasol results in decreased expression of ARID2 mRNA CTD PMID:27462272 Arid2 Rat coumarin decreases phosphorylation ISO RGD:1322383 6480464 coumarin results in decreased phosphorylation of ARID2 protein CTD PMID:35688186 Arid2 Rat crocidolite asbestos decreases expression ISO RGD:1322384 6480464 Asbestos, Crocidolite results in decreased expression of ARID2 mRNA CTD PMID:29279043 Arid2 Rat dexamethasone multiple interactions ISO RGD:1322383 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Arid2 Rat Dibutyl phosphate affects expression ISO RGD:1322383 6480464 di-n-butylphosphoric acid affects the expression of ARID2 mRNA CTD PMID:37042841 Arid2 Rat dioxygen multiple interactions ISO RGD:1322384 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARID2 mRNA CTD PMID:30529165 Arid2 Rat dorsomorphin multiple interactions ISO RGD:1322383 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Arid2 Rat doxorubicin decreases expression ISO RGD:1322383 6480464 Doxorubicin results in decreased expression of ARID2 mRNA CTD PMID:29803840 Arid2 Rat ethanol affects splicing ISO RGD:1322384 6480464 Ethanol affects the splicing of ARID2 mRNA CTD PMID:30319688 Arid2 Rat ethyl methanesulfonate decreases expression ISO RGD:1322383 6480464 Ethyl Methanesulfonate results in decreased expression of ARID2 mRNA CTD PMID:23649840 Arid2 Rat formaldehyde decreases expression ISO RGD:1322383 6480464 Formaldehyde results in decreased expression of ARID2 mRNA CTD PMID:20655997|PMID:23649840 Arid2 Rat FR900359 affects phosphorylation ISO RGD:1322383 6480464 FR900359 affects the phosphorylation of ARID2 protein CTD PMID:37730182 Arid2 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ARID2 mRNA CTD PMID:22061828 Arid2 Rat hydrogen peroxide multiple interactions ISO RGD:1322383 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ARID2 protein CTD PMID:18951874 Arid2 Rat indometacin multiple interactions ISO RGD:1322383 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Arid2 Rat irinotecan decreases expression ISO RGD:1322383 6480464 Irinotecan analog results in decreased expression of ARID2 mRNA CTD PMID:18927307 Arid2 Rat Lasiocarpine multiple interactions ISO RGD:1322383 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ARID2 more ... CTD PMID:33884520 Arid2 Rat methapyrilene increases methylation ISO RGD:1322383 6480464 Methapyrilene results in increased methylation of ARID2 intron CTD PMID:30157460 Arid2 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of ARID2 gene CTD PMID:35440735 Arid2 Rat methyl methanesulfonate decreases expression ISO RGD:1322383 6480464 Methyl Methanesulfonate results in decreased expression of ARID2 mRNA CTD PMID:23649840 Arid2 Rat methylmercury chloride decreases expression ISO RGD:1322383 6480464 methylmercuric chloride results in decreased expression of ARID2 mRNA CTD PMID:26272509 Arid2 Rat monocrotaline multiple interactions ISO RGD:1322383 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of ARID2 more ... CTD PMID:33884520 Arid2 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ARID2 mRNA CTD PMID:25729387 Arid2 Rat panobinostat affects expression ISO RGD:1322383 6480464 panobinostat affects the expression of ARID2 mRNA CTD PMID:26733615 Arid2 Rat panobinostat multiple interactions ISO RGD:1322383 6480464 (+)-JQ1 compound promotes the reaction [panobinostat affects the expression of ARID2 mRNA]; panobinostat promotes the more ... CTD PMID:26733615 Arid2 Rat paracetamol increases expression ISO RGD:1322383 6480464 Acetaminophen results in increased expression of ARID2 mRNA CTD PMID:26690555 Arid2 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ARID2 mRNA CTD PMID:33387578 Arid2 Rat pirinixic acid multiple interactions ISO RGD:1322384 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Arid2 Rat potassium dichromate decreases expression ISO RGD:1322384 6480464 Potassium Dichromate results in decreased expression of ARID2 mRNA CTD PMID:23608068 Arid2 Rat quercetin decreases expression ISO RGD:1322383 6480464 Quercetin results in decreased expression of ARID2 mRNA CTD PMID:21632981 Arid2 Rat riddelliine multiple interactions ISO RGD:1322383 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ARID2 more ... CTD PMID:33884520 Arid2 Rat SB 431542 multiple interactions ISO RGD:1322383 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Arid2 Rat sodium arsenate increases expression ISO RGD:1322384 6480464 sodium arsenate results in increased expression of ARID2 mRNA CTD PMID:21795629 Arid2 Rat sodium arsenite decreases expression ISO RGD:1322383 6480464 sodium arsenite results in decreased expression of ARID2 mRNA CTD PMID:38568856 Arid2 Rat sunitinib decreases expression ISO RGD:1322383 6480464 Sunitinib results in decreased expression of ARID2 mRNA CTD PMID:31533062 Arid2 Rat theophylline multiple interactions ISO RGD:1322383 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ARID2 protein CTD PMID:18951874 Arid2 Rat titanium dioxide decreases expression ISO RGD:1322384 6480464 titanium dioxide results in decreased expression of ARID2 mRNA CTD PMID:29264374 Arid2 Rat titanium dioxide increases methylation ISO RGD:1322384 6480464 titanium dioxide results in increased methylation of ARID2 gene CTD PMID:35295148 Arid2 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ARID2 mRNA CTD PMID:25729387 Arid2 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of ARID2 mRNA CTD PMID:25729387 Arid2 Rat trichostatin A decreases expression ISO RGD:1322383 6480464 trichostatin A results in decreased expression of ARID2 mRNA CTD PMID:24935251|PMID:26272509 Arid2 Rat trichostatin A affects expression ISO RGD:1322383 6480464 trichostatin A affects the expression of ARID2 mRNA CTD PMID:28542535 Arid2 Rat trichostatin A multiple interactions ISO RGD:1322383 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Arid2 Rat triphenyl phosphate affects expression ISO RGD:1322383 6480464 triphenyl phosphate affects the expression of ARID2 mRNA CTD PMID:37042841 Arid2 Rat troglitazone decreases expression ISO RGD:1322384 6480464 troglitazone results in decreased expression of ARID2 mRNA CTD PMID:28973697 Arid2 Rat tungsten decreases expression ISO RGD:1322384 6480464 Tungsten results in decreased expression of ARID2 mRNA CTD PMID:30912803 Arid2 Rat valproic acid decreases methylation ISO RGD:1322383 6480464 Valproic Acid results in decreased methylation of ARID2 gene CTD PMID:29154799 Arid2 Rat valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of ARID2 mRNA CTD PMID:29427782 Arid2 Rat valproic acid decreases expression ISO RGD:1322383 6480464 Valproic Acid results in decreased expression of ARID2 mRNA CTD PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369 Arid2 Rat valproic acid multiple interactions ISO RGD:1322383 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Arid2 Rat valproic acid increases expression ISO RGD:1322383 6480464 Valproic Acid results in increased expression of ARID2 mRNA CTD PMID:26705709 Arid2 Rat valproic acid decreases expression ISO RGD:1322384 6480464 Valproic Acid results in decreased expression of ARID2 mRNA CTD PMID:21427059 Arid2 Rat valproic acid affects expression ISO RGD:1322383 6480464 Valproic Acid affects the expression of ARID2 mRNA CTD PMID:25979313 Arid2 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ARID2 mRNA CTD PMID:19015723 Arid2 Rat vincristine increases expression ISO RGD:1322383 6480464 Vincristine results in increased expression of ARID2 mRNA CTD PMID:23649840 Arid2 Rat zoledronic acid decreases expression ISO RGD:1322383 6480464 zoledronic acid results in decreased expression of ARID2 mRNA CTD PMID:20977926
(-)-demecolcine (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 2,6-dinitrotoluene (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) acetazolamide (ISO) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) amphetamine (EXP) aristolochic acid A (ISO) atrazine (ISO) benzene (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[e]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) butanal (ISO) cadmium dichloride (ISO) caffeine (ISO) carbon nanotube (ISO) chlordecone (ISO) chloroprene (EXP) chlorpyrifos (ISO) cisplatin (ISO) clobetasol (ISO) coumarin (ISO) crocidolite asbestos (ISO) dexamethasone (ISO) Dibutyl phosphate (ISO) dioxygen (ISO) dorsomorphin (ISO) doxorubicin (ISO) ethanol (ISO) ethyl methanesulfonate (ISO) formaldehyde (ISO) FR900359 (ISO) gentamycin (EXP) hydrogen peroxide (ISO) indometacin (ISO) irinotecan (ISO) Lasiocarpine (ISO) methapyrilene (ISO) methoxychlor (EXP) methyl methanesulfonate (ISO) methylmercury chloride (ISO) monocrotaline (ISO) oxaliplatin (EXP) panobinostat (ISO) paracetamol (EXP,ISO) pirinixic acid (ISO) potassium dichromate (ISO) quercetin (ISO) riddelliine (ISO) SB 431542 (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sunitinib (ISO) theophylline (ISO) titanium dioxide (ISO) topotecan (EXP) trichostatin A (ISO) triphenyl phosphate (ISO) troglitazone (ISO) tungsten (ISO) valproic acid (EXP,ISO) vinclozolin (EXP) vincristine (ISO) zoledronic acid (ISO)
Biological Process
biological_process (ND) cardiac muscle cell proliferation (IEA,ISO) chromatin remodeling (IBA) circulatory system development (IEA,ISO) coronary artery morphogenesis (IEA,ISO) embryonic organ development (IEA,ISO) heart morphogenesis (IEA,ISO) homeostatic process (IEA,ISO) negative regulation of cell migration (IEA,ISO) negative regulation of cell population proliferation (IEA,ISO) nucleosome disassembly (IEA,ISO) positive regulation of double-strand break repair via homologous recombination (IEA,ISO) regulation of DNA-templated transcription (IEA)
1.
Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer.
Bala P, etal., Oncogene. 2021 Jan;40(4):863-874. doi: 10.1038/s41388-020-01537-z. Epub 2020 Dec 1.
2.
Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y, etal., Oncotarget. 2016 Jul 19;7(29):45863-45875. doi: 10.18632/oncotarget.10244.
3.
HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma.
Gao Q, etal., Cancer Sci. 2017 Jul;108(7):1328-1337. doi: 10.1111/cas.13277. Epub 2017 Jun 14.
4.
ATP-dependent chromatin remodeling: genetics, genomics and mechanisms.
Hargreaves DC and Crabtree GR, Cell Res. 2011 Mar;21(3):396-420. doi: 10.1038/cr.2011.32. Epub 2011 Mar 1.
5.
Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.
Jiang H, etal., Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4770-4780. doi: 10.1073/pnas.1914937117. Epub 2020 Feb 18.
6.
GOA pipeline
RGD automated data pipeline
7.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
8.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
9.
Comprehensive gene review and curation
RGD comprehensive gene curation
10.
The spectrum of SWI/SNF mutations, ubiquitous in human cancers.
Shain AH and Pollack JR, PLoS One. 2013;8(1):e55119. doi: 10.1371/journal.pone.0055119. Epub 2013 Jan 23.
11.
MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
Wu M, etal., Biomed Pharmacother. 2020 Feb;122:109696. doi: 10.1016/j.biopha.2019.109696. Epub 2019 Dec 30.
12.
AT-rich interactive domain 2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and clinicopathologic implications.
You J, etal., Hum Pathol. 2015 Apr;46(4):583-92. doi: 10.1016/j.humpath.2015.01.001. Epub 2015 Jan 14.
Arid2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 129,326,371 - 129,443,813 (+) NCBI GRCr8 mRatBN7.2 7 127,447,192 - 127,565,987 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 127,447,278 - 127,563,512 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 7 137,680,564 - 137,798,329 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 137,680,530 - 137,795,655 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 137,312,585 - 137,430,353 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 134,959,992 - 135,077,477 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 135,036,399 - 135,153,718 (+) NCBI Celera 7 123,951,414 - 124,071,020 (+) NCBI Celera Cytogenetic Map 7 q35 NCBI
ARID2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 12 45,729,706 - 45,908,037 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 12 45,729,706 - 45,908,040 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 12 46,123,489 - 46,301,820 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 12 44,409,887 - 44,588,086 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 12 44,920,557 - 45,099,159 (+) NCBI Celera Cytogenetic Map 12 q12 NCBI HuRef 12 43,152,842 - 43,332,608 (+) NCBI HuRef CHM1_1 12 46,088,579 - 46,266,707 (+) NCBI CHM1_1 T2T-CHM13v2.0 12 45,688,334 - 45,867,621 (+) NCBI T2T-CHM13v2.0
Arid2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 15 96,185,403 - 96,303,344 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 15 96,185,399 - 96,302,873 (+) Ensembl GRCm39 Ensembl GRCm38 15 96,287,522 - 96,405,463 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 15 96,287,518 - 96,404,992 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 15 96,117,953 - 96,235,894 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 15 96,197,538 - 96,230,331 (+) NCBI MGSCv36 mm8 Celera 15 98,438,688 - 98,556,626 (+) NCBI Celera Cytogenetic Map 15 F1 NCBI cM Map 15 52.37 NCBI
Arid2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955500 4,998,555 - 5,175,776 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955500 4,998,555 - 5,177,180 (+) NCBI ChiLan1.0 ChiLan1.0
ARID2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 10 48,261,225 - 48,443,133 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 12 48,257,983 - 48,439,555 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 12 42,823,236 - 43,004,465 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 12 43,692,717 - 43,871,652 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 12 43,692,914 - 43,871,564 (-) Ensembl panpan1.1 panPan2
ARID2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 27 8,411,092 - 8,579,735 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 27 8,412,377 - 8,579,882 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 27 37,733,310 - 37,902,134 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 27 8,605,853 - 8,775,028 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 27 8,605,848 - 8,775,217 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 27 8,413,511 - 8,582,264 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 27 8,452,603 - 8,621,753 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 27 37,971,938 - 38,141,085 (+) NCBI UU_Cfam_GSD_1.0
Arid2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404945 68,966,896 - 69,144,185 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936512 4,020,966 - 4,196,459 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936512 4,020,303 - 4,199,390 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
ARID2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 5 76,636,967 - 76,797,043 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 5 76,637,385 - 76,800,155 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 5 79,655,352 - 79,725,991 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
ARID2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 11 41,933,650 - 42,117,495 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 11 42,028,083 - 42,118,892 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666037 204,323,064 - 204,512,703 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Arid2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 222 Count of miRNA genes: 160 Interacting mature miRNAs: 175 Transcripts: ENSRNOT00000006970, ENSRNOT00000072800 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1300179 Kidm5 Kidney mass QTL 5 3.51 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 7 43747012 135012528 Rat 1354582 Stl11 Serum triglyceride level QTL 11 3.42 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 7 119513385 135012528 Rat 731176 Glom5 Glomerulus QTL 5 2.5 0.0035 kidney glomerulus morphology trait (VT:0005325) count of superficial glomeruli not directly contacting the kidney surface (CMO:0001002) 7 96670164 135012528 Rat 1300112 Bp183 Blood pressure QTL 183 3.51 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 7 111182207 135012528 Rat 2306821 Bp335 Blood pressure QTL 335 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 7 106571501 135012528 Rat 631663 Bw6 Body weight QTL 6 3.4 body mass (VT:0001259) body weight (CMO:0000012) 7 111075573 134976056 Rat 1331731 Bp216 Blood pressure QTL 216 2.851 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 102297359 133492884 Rat 2298475 Eau6 Experimental allergic uveoretinitis QTL 6 0.0029 uvea integrity trait (VT:0010551) experimental autoimmune uveitis score (CMO:0001504) 7 84257275 129257275 Rat 1558655 Swd4 Spike wave discharge measurement QTL 4 3.68 0.0002 brain electrophysiology trait (VT:0010557) brain spike-and-wave discharge severity grade (CMO:0001988) 7 86983365 131983365 Rat 71114 Niddm14 Non-insulin dependent diabetes mellitus QTL 14 4.5 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 7 84257275 129257275 Rat 731174 Uae23 Urinary albumin excretion QTL 23 2.4 0.0042 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 7 104603555 135012528 Rat 631687 Hcas1 Hepatocarcinoma susceptibility QTL 1 3.9 0.001 liver integrity trait (VT:0010547) liver tumorous lesion volume to total liver volume ratio (CMO:0001082) 7 91412594 129807172 Rat 1357339 Stl14 Serum triglyceride level QTL 14 3.45 0.0001 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 7 112729683 133492707 Rat 1331748 Bp215 Blood pressure QTL 215 4.043 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 112308254 133492884 Rat 634331 Pia17 Pristane induced arthritis QTL 17 4.7 joint integrity trait (VT:0010548) arthritic paw count (CMO:0001460) 7 73829340 130221005 Rat 1358914 Bp266 Blood pressure QTL 266 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 83591953 134666232 Rat 2299163 Iddm34 Insulin dependent diabetes mellitus QTL 34 2.71 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 7 91281130 135012528 Rat 634322 Bw12 Body weight QTL 12 0 body mass (VT:0001259) body weight (CMO:0000012) 7 83153392 128153392 Rat 70173 Niddm19 Non-insulin dependent diabetes mellitus QTL 19 4.33 0.00005 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 7 64002457 135012528 Rat 1549899 Stresp8 Stress response QTL 8 4.37 0.0008 stress-related behavior trait (VT:0010451) defensive burying duration (CMO:0001961) 7 90482196 135012528 Rat 1358891 Bp265 Blood pressure QTL 265 2.21 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 83591953 134666232 Rat
D7Got154
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 127,455,195 - 127,455,343 (+) MAPPER mRatBN7.2 Rnor_6.0 7 137,687,927 - 137,688,074 NCBI Rnor6.0 Rnor_5.0 7 137,319,951 - 137,320,098 UniSTS Rnor5.0 RGSC_v3.4 7 134,969,369 - 134,969,516 RGD RGSC3.4 RGSC_v3.4 7 134,969,369 - 134,969,516 UniSTS RGSC3.4 RGSC_v3.1 7 135,045,806 - 135,045,953 RGD Celera 7 123,961,191 - 123,961,343 UniSTS RH 3.4 Map 7 1092.0 RGD RH 3.4 Map 7 1092.0 UniSTS RH 2.0 Map 7 773.9 RGD Cytogenetic Map 7 q35 UniSTS
RH143678
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 127,445,042 - 127,445,162 (+) MAPPER mRatBN7.2 Rnor_6.0 7 137,678,394 - 137,678,513 NCBI Rnor6.0 Rnor_5.0 7 137,310,390 - 137,310,509 UniSTS Rnor5.0 RGSC_v3.4 7 134,959,850 - 134,959,969 UniSTS RGSC3.4 Celera 7 123,951,272 - 123,951,391 UniSTS RH 3.4 Map 7 1098.9 UniSTS Cytogenetic Map 7 q35 UniSTS
BF398770
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 127,460,365 - 127,460,572 (+) MAPPER mRatBN7.2 Rnor_6.0 7 137,693,095 - 137,693,301 NCBI Rnor6.0 Rnor_5.0 7 137,325,119 - 137,325,325 UniSTS Rnor5.0 RGSC_v3.4 7 134,974,537 - 134,974,743 UniSTS RGSC3.4 Celera 7 123,966,364 - 123,966,570 UniSTS RH 3.4 Map 2 180.4 UniSTS Cytogenetic Map 7 q35 UniSTS
ARID2_3730
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 127,563,909 - 127,564,650 (+) MAPPER mRatBN7.2 Rnor_6.0 7 137,796,251 - 137,796,991 NCBI Rnor6.0 Rnor_5.0 7 137,428,275 - 137,429,015 UniSTS Rnor5.0 RGSC_v3.4 7 135,078,075 - 135,078,815 UniSTS RGSC3.4 Celera 7 124,068,942 - 124,069,682 UniSTS Cytogenetic Map 7 q35 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000006970 ⟹ ENSRNOP00000006970
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 7 127,447,278 - 127,563,512 (+) Ensembl Rnor_6.0 Ensembl 7 137,680,530 - 137,795,655 (+) Ensembl
RefSeq Acc Id:
XM_063264356 ⟹ XP_063120426
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 129,343,693 - 129,443,813 (+) NCBI
RefSeq Acc Id:
XM_345867 ⟹ XP_345868
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 129,326,371 - 129,443,813 (+) NCBI mRatBN7.2 7 127,447,192 - 127,565,987 (+) NCBI Rnor_6.0 7 137,680,564 - 137,798,329 (+) NCBI Rnor_5.0 7 137,312,585 - 137,430,353 (+) NCBI RGSC_v3.4 7 134,959,992 - 135,077,477 (+) RGD
Sequence:
CCGCCGCCGCCGCCGCCGCCGCCGCCGCCACCGCCGGCCCATGACTGAGCCCCGCCACCGCCGGCCGAGGAATGGGCTCCGGGCGCTGGTAGGGAGCGCGGGGAGCGGGGGCCGCGTTTGAACCGCGA TCTGGGTTTTCGGGAGACCTCCTTTGGCAAAATAATGGCAAACTCGACGGGGAAGGCGCCTCCGGACGAGCGGAGGAAGGGACTGGCTTTCCTGGACGAGCTGCGGCAGTTCCACCACAGCAGAGGGT CGCCGTTTAAGAAGATCCCTGCGGTGGGTGGGAAGGAGCTGGATCTTCACGGGCTCTACACCAGAGTCACTACTTTAGGCGGATTCGCGAAGGTTTCTGAGAAGAATCAGTGGGGAGAAATTGTTGAA GAGTTCAACTTTCCCAGAAGTTGTTCTAACGCTGCCTTTGCTTTAAAACAGTATTACTTGCGTTATCTAGAAAAGTACGAGAAAGTTCACCATTTCGGGGAAGATGATGATGAGGTACCACCGGGCAA TCCAAAGCCACAGCTCCCTATTGGTGCGATTCCGTCTTCCTACAACTACCAGCAGCACAGCGTGTCAGATTATCTACGTCAAAGTTATGGGTTATCTATGGATTTTAATTCGCCAAATGATTATAATA AACTGGTGCTTTCACTGTTATCTGGACTCCCAAACGAAGTGGACTTCGCCATTAATGTGTGCACTCTCCTCTCAAACGAAAGCAAGCACGTCATGCAGCTTGAAAAAGATCCCAAAATCATCACTTTA TTACTTGCTAATGCTGGGGTGTTTGATGACACTTTAGGCTCGTTCTCTACTGTCTTTGGAGAAGAATGGCGAGAGAAGACTGACAGAGACTTTGTTAAGTTTTGGAAAGACATTGTGGATGACAATGA AGTGCGAGATCTCATTTCTGACAGAAACAAGGCTCATGAAGATACACCAGGAGAATGGATTTGGGAATCTTTATTTCATCCACCTCGAAAGCTGGGCATTAACGACATCGAAGGACAGCGGGTTCTTC AGATTGCAGTGATTTTGCGAAACCTTTCCTTTGAGGAGAGCAATGTTAAGCTCTTGGCAGCTAATCGCACCTGTCTTCGTTTCCTATTACTCTCTGCACATAGTCATTTTATTTCATTAAGGCAATTA GGCCTTGACACGTTAGGAAATATTGCAGCTGAGCTTTTACTGGACCCTGTTGATTTCAAAACCACTCATCTGATGTTTCATACTGTTACGAAATGCCTGATGTCAAGGGATAGGTTTTTAAAGATGAG GGGCATGGAAATTTTGGGAAATCTTTGCAAAGCAGAGGATAATGGTGTTTTGATTTGTGAATATGTGGATCAAGATTCATATAGAGAGATAATTTGTCACCTCACTTTGCCCGATGTGCTGCTTGTAA CCTCAACTCTAGAGGTGCTCTACATGCTCACCGAAATGGGGGACATTGCCTGCACAAAGATCGCAAAAGTAGAAAAGAGCATAGACATGCTCGTGTGTCTGGTTTCCATGGACATTCAGATGTTTGGC CCTGATGCACTAGCTGCAGTGAAGCTTGTTGAACATCCAAGCTCCAGTCACCAAGTTTTATCTGAAATGAGGCCACAGGCTATAGAGCAGGTCCAAACCCAGAGCCACGGGGCACCTGGCCCAGCTTG CAGAGCAGTTGTAGCACAGCACGCCGCTCCCCCTCCAGGCATCGTGGAAATAGACAGTGAGAAGTTCGCTTGTCAGTGGCTAAATGCTCATTTTGAAGTAAATCCAGATTGTTCAGTCTCTCGGGCAG AAATGTATTCCGAGTATCTCTCAACTTGTAGTAAATTAGCTCGTGGTGGCATCCTCACATCGACTGGGTTTTACAAGTGTCTTAGAACAGTTTTTCCAAATCACACAGTGAAGAGAGTGGAAGACTCC AGTAGCAGCGGGCAGGCACATATCCACGTCATAGGTGTGAGACGGAGGGCTCTGCCGCTGCCCATTCAGATGTACTATCAGCAGCAGCCGGTTTCAACTCCCGTTGTTCGAGTCGATGCTGTTGCTGA CGTGTCTCCAACTCCTTCACCTGCAGGAATCCCTCACGGATCACAAGCTGTGGGAAATCATTTTCAGAGGACTCCTGTCACCAATCAATCTTCAAATTTGACTGCAACACAAATGTCTTTTCCAGTAC AAGGCGTTCATACTGTGGCACAGACTGTTTCTAGAATTCCACCGAATCCTTCAGTTCATACCCACCAGCAACAAAATTCTCCAGTGACTGTCATTCAGAATAAAGCTCCAATTCCCTGTGAAGTCGTT AAGGCAACAGTAATCCAGAACTCTGTCCCCCAGACAGCAGTTCCTGTGAGTATCGCTGTTGGAGGACCTGCACAGAGCTCTTTAGCTCAGAATCATAGTGCAGGGCCACAGCCTGTTACAGTTGTAAA TTCTCAGACATTGCTTCACCATCCCTCTGTGATGCCACAGCCATCTCCACTACACACAGTGGTGCCAGGACAGATCCCGTCAGGAACTCCTGTCACAGTAATCCAGCAAACTGTACCACAGAGTCATA TATTTGGACGAGTACAGAACATACCAGCATGTACGTCCACAGTTTCACAGGGTCAGCAGTTAATCACCACGTCACCACAGCCTATGCACACGTCATCTCAACAGACAGCAGCTGGTAGCCAGCCACAG GACACTGTCATCATAGCACCTCCACAGTACGTAACAACTTCTGCATCCAGTATCGTCTCAGCAACTTCAGTACAGAATTTCCAGGTAGCTACGGGACAGGTAGTTACCATAGCTGGTGTTCCAAGTCC ACAACCCTCCAGGGTGGGATTCCAGAACATTGCACCCAAGCCGCTTCCTTCTCAGCACGTTTCATCGACAGTGGTACAGCAGCCTGTTCAACAACCACAGCAGCCAGCCCAGCAAAGCGTAGTGATCG TAAGCCAGCCAGCTCAGCAAGGCCAGACTTACGCACCAGCCATTCACCAAATTGTTCTTGCTAACCCGGCAGCTCTCCCAACTGGTCAGACAGTTCAGCTGACTGGACAACCAAACATAACTCCATCT TCTTCACCATCACCTGTCCCAGCTACTAGTAACCAAGTCCCTGCGGCCATGTCATCTTCTTCCACCCTTCAGTCACAGGGACCCCCTCCTACTGTCAGTCAGATGCTGTCTGTGAAGAGGCAGCAGCA GCAGCAGCATTCACCAGCGGCGCCAGCACAGCAGGTCCAGGTCCAGGTGCAGCCGCCGCAAGTCCAGGTGCAAGTGCAGCCCCAGCAGGCGGGTGCAGGAGTTGGTCAGCCCGCTTCCAGCGAGTCTA GTCTGATAAAACAGCTGCTGCTCCCAAAGCGGGGCCCTTCCACCCCAGGGGGTAAGCTTATCCTCCCAGCCCCACAGATTCCTCCCCCTAACAATGCCAGAGCCCCCAGCCCCCAGGTGGTCTATCAG GTGGCCAATAGCCAAGCAGCTGGCTTTGGCGCGCAGGGGCAGACCCCTGCTCAGCAGCTGCTGGTTGGACAGCCAAATGTTCAGTTGGTCCAAAGTGCAATGCCACCCACGGGGGGAGTGCAAACTGT GCCCATTTCCAACTTACAAATACTGCCGGGTCCACTGATCTCAAACAGCCCAGCAACCATTTTCCAAGGGACTTCCGGCAACCAGGTAACTATAACAGTTGTGCCAAATACCAGTTTTGCAACTGCGA CTGTGAGTCAGGGAAACGCAGCTCAGCTCATCGCTCCAGCCGGTATTAGCATGAGTGGGGCGCAGGCCGGAGCTGGACTTCAGGTGCAGACGCTTCCAGCCGGACAGTCAGCGTGTACCAGCGCTGCC CCCCCATTCAAAGGCGATAAGATCATTTGCCAAAAGGAGGAGGAGGCAAAGGAAGCAACAGGTCTACATGTTCATGAGCGGAAAATCGAGGTCATGGAGAATCCTTCCTGCCGACGAGGAACCACGAA CACCAGCAATGGGGACACGAGTGAGAGTGAGACCCAGGTGGGGAGCCTGTTAAACGGGAGAAAGTACAGTGACTCAAGTCTACCTCCTTCACACTCAGGGAAACTTCAGAGTGAGCCCAACCCGTGCT CACCACTCAGCAATGGGCCATCGTTGGAATTAGGTGAGAATGGAGCATCTGGAAAACAGAACTCAGAACCAGTGGACATGCAGGATGTCAAAAGTGATCTGAAAAAAACCCTTGTTAATGGAATCTGT GATTTTGATAAAGGAGATGGTTCTCATTTAAGCAAAAACATTCCAAATCACAAAACTTGTAATCATGTAGGAAACGGTGAGGTATCTCCAGTGGAGCCACAGGGGACTTTGGGTGCCACCCAGCAAGA GACTGCCAAAGGCGACCAGCTAGAAAGAGTTCCCAATGGACCCGCGTTAACTCTGGGTGGGTCACCGGCCACCAGCAGTGTGCAAGAAGCTTCGAGTGTGGCGACACAGCCATTCAGTGGTACTGACT TGCCTAACGGACCTCTAGCTTCAGGTTTGACTTCAGATGTGCCTCATCAGCGCCCAAGTGTGGTTGTCTCACCGCGTCCTACAGCCCCTGTCATACAGGGGCACCCGGTCATAGCAGCTCCCCACTCA GGATCTAGAGGGCCCGCCTCCGCTCTGTCATCTGACGCTCGGTCTACAAACGGCACAGCCGAGTGCAAAACTGTGAAGAGGCCAGCAGAGGATGGCGATAGGGAAGCAGCCCCGGGAATTCCAAATAA AGTAGGGGTCAGAATTGTCACAATCAGCGACCCCAACAATGCTGGCTGCAGTGCCACCATGGTGGCTGTCCCAGCAGGCGCCGACCCGAGCACTGTAGCTAAAGTAGCAATAGGAAGCGCAGCTCAGC AGAAGCCGCCGCCGCCGCCAGCCTACGCGCAGAGCGCGCTCCCACAGAACACTCCTATGCCACCTTCACCAGCTGTTCAGGTGCAGGGCCAGCCTAGCAGTTCTCAGCCTTCTCCAGTCAGTGCGTCC AGTCAGCATGCAGATCCAGTGAGAAAACCTGGGCAGAACTTCATGTGTCTGTGGCAGTCTTGTAAAAAGTGGTTTCAGACGCCGTCACAAGTGTTCTACCACGCGGCCACTGAACATGGAGGGAAGGA TGTGTACCCGGGGCAGTGCCTCTGGGAAGGCTGCGAGCCCTTCCAGCGGCAAAGGTTCTCGTTCATCACCCACTTACAGGACAAGCACTGTTCAAAGGACGCTCTGCTTGCAGGGTTAAAACAAGATG AACCAGGACAAGCGGCAAATCAAAAATCTTCTACCAAGCAGCCCACTGTGGGGAGCACAGGCTCTGCTCCCAGAGCCCAGAAGGCCATTGCAAGCCACCCCAGTGCTGCACTCATGGCTCTGCGGAGA GGCTCGAGGAACCTTGTCTTCCGGGACTTTACAGATGAAAAAGAGGGACCAATAACTAAACACATCCGACTAACAGCTGCCTTAATATTAAAAAATATTGGTAAATACTCAGAGTGTGGGCGCAGATT GTTAAAAAGACATGAAAACAACTTATCAGTGCTAGCCATTAGTAACATGGAGGCTTCCTCTACCCTTGCCAAATGCCTTTATGAACTTAATTTTACAGTTCAGAGTAAAGAACAAGAACAAGACTCAG AAATGCTGTAGTGAATCCTACCCCACTGACACAGTGGGGGCTCAAAGTCAAACACATTTCACTGTTACTGAAGAAAGCACCAAGTCTTAATGGAGCAGAGACCATAGAATGAATTATTTTGTGTCCTC CCATGATGCTGAGAGGAAGCTTCGTATTCTGATCTCTGAACGAATCCCTTTCTTTTCTGTTAAAAAAAAATCTAAAAAGGAAAAAAAAAAAAAACAAACAAACTGCTGTGGGATTGACAACCAGCCTA TCTGCAGGATGTCTCGGGTCTGGCCAATCCTGATGGAAACTGGTGTGATCAGAATTCTGTACCATCCACATTGGAATATACATGGAATAGTGTAAAACCTACGTGAGCAGATGAAATAGAAGCATTAA ATATTTTTATCTATATCCAAAAAGGAGCACATTTTTATATTTACAGAACCATTTAAGCTGGTTTGAATAACGACGACAAAGTTTGAGCACACCTATCCCCCAGCTTCGGAGGGGCCACCAGTATCTAG CTGTGGATTGTGTGTTTTGTTTAGAATCAGTAGCTTGGTTTTCTTACTTGAGCCAATATATTTTCACTTATTTATTATCATAAAAATTTACCAGTCTGAATAGATCTTGTAAATATTTGTGAATAGAA TGAACACCGTTCATACCACTGCAGCCACTGGAAATCATTCTGTGGTGTCCTGGAAGCATTATCGGTAGGCTCTAAAGTTTTCTAGACTTTGCTGTCACCTGTAATTGTGATGTATTCTAGGCAGTGGT GGACACTCTTACATTTGTGTAAATACTTCTGCAGAGGTACTGATGCTGTAAAGTCAACAGTTTTGTGGAACTGTGATTTTTTTTTCCCCCTCCTTTTTTTGGTTTCCTTGGATCCCACTCCCTTGGGT GGGGTTTTTTTGGGTTTTTTTGTTTGTTTTGTTTTGTATTATACACCTTGTAGAACTCATTTTGCTGGCTGAAAGAGTATGGAATAATATATCTCATGTCATTTTTGTAGAAGAAAAACTATTTGAAT TTTTTTTTGTTTGGTTTTCCCTCCCATGTATCCACTGTAAGCATTTGTCATGTGCAAGCTCAGAGCTTGTGCAGAATTTTTTGTATTTGTAAATTGGTTTAAATACATGGAATTTTATACAGGTTTTC TCCTGTGTTATATATGCATTATGTGCAGGTATGATATTTTCTTCACTACTTTTTCTATCTTAATATAGTGTGGAATTTTATTGTATTATTCTTCCATTCTTAATACTGTACCACATTCCTGCTCAAAA ACTGCTCACTTCCTTAAATTGTCTTTTTTCCCCCTAAGCGTGAAATGTATCCACTTATAACTGCCTATTGCCTGTTCTATTAGCATCCAAAAATGTGGAAGGCCTCCCAACAACCATTTCTGCTGTGT CCTTAGGATGTGCAGTAAAAAATATAGACCTGACAGTTTATGTTATAGAATGGCTTTATTTACTTTGGTGACTGTTTATAGTTTTTAAATAAAAGACTGAACATTTTCTTGAGTCCTTTATTTCTGAG TATGCTTAAGACATTGTAAAATTTAAAGTCTAGCTGAAGGCAAAGTCAAACGGTCACCTCCTTTATACTTTGTGATAATATTGTAGAGAGCAGAAAGGTGCATCAGATGACATACACCATGGTCATGG CAGGAAAACCAAACTTTTTGTTTACGATATTTAGGAGCAGTAAGCCCAGTGAGAGACAGTTCAGAGCTCAGCTGCCTTACCCTTGTGTCAGCATCTGACTGAAGCTTTTCTTTACCATTTGACTGTAG GTTGAATTCAGAGGCAGATTTTTTAATGAGCTTCAGTCTGGACATACATTTTCAGCATCTTGATTCACTAATTATTACCTGAAGTAATTTCTCCCCAAGGGGCCTCTGCCTGTGTACTCGGCTCTATC TGTAAAACGATGTGTGGAAACACCCAAAACTCGGTATTCTCAGGTTGTTGGCATTGACTTCTTCACCTTAGACTGGGGCTGCCCAGCAGACAGCCTGGGTCCAGATACCTTATTATATCCCGCAAATA TTTCCAGACTAAAGGTTCCTAAGGGCAGATGGTGGCAGACATTTATATTCACTGTGTTTATCTAAAAAATTTGAGGCTTTCTGAAATAATTTTTGTAACATCACTGTTTGCTTCTCTTCAAGGTACCT TTTACCTTTCAAAGCAGGAAATTACCACGGTGGTTAACTTTTAGTAGCAGAAACAACAGGCTTAAAGTGATTTCCACAGTCACCATCTTGTCACCTCACTGAATTGCATCCTGTAGTTGTAGGTTTTG TGTTAAAATGTATAAATGTGTCTTTAGTGCTTTTAAGCAATGGTCTCAGCAGAATTTTCTCAATGTACTTGACCTGAGGAAACCAATTTCTAGCTTCCCTCTTAGGCTTTCCCTCCGACAGCTTTACC TGACTAGCGGACTAACACGGACTTGGTGGGTGACGCAGCTGAAGTGCCCTTGAGTCCAGGTCCTGCAGAACCCTCAGTCATGAAAAGGTGCTCCGTGCTAGACAGAAACTTGCTGACTTCCAGTATTG TTATTTTTGTCTAAAGTTGTGTAAATACAAGCTTTGATGTTATCTTTGAGAAATCTATGTAAATAATAGTCAACAACATAGACTGTACAATTCTGTGTTATATATGTGCCTAGTGCTCTGTTGGCACT TAATAAATTTTAAGTAACAAAACTGATGATCATATAGTGAAGGCATATTTTTCTTCCGACTTGACAGGATATGACTATATATTAATGAGACTCAATAAACCAAGCCACACATGAAAACTTGTCTCATT ACTTTATAGCCATGCCATGTATGTTTTTTAAACCATAAATGACAATAAAAGTGATTTTTGAAATGAG
hide sequence
RefSeq Acc Id:
XP_345868 ⟸ XM_345867
- Peptide Label:
isoform X1
- Sequence:
MANSTGKAPPDERRKGLAFLDELRQFHHSRGSPFKKIPAVGGKELDLHGLYTRVTTLGGFAKVSEKNQWGEIVEEFNFPRSCSNAAFALKQYYLRYLEKYEKVHHFGEDDDEVPPGNPKPQLPIGAIP SSYNYQQHSVSDYLRQSYGLSMDFNSPNDYNKLVLSLLSGLPNEVDFAINVCTLLSNESKHVMQLEKDPKIITLLLANAGVFDDTLGSFSTVFGEEWREKTDRDFVKFWKDIVDDNEVRDLISDRNKA HEDTPGEWIWESLFHPPRKLGINDIEGQRVLQIAVILRNLSFEESNVKLLAANRTCLRFLLLSAHSHFISLRQLGLDTLGNIAAELLLDPVDFKTTHLMFHTVTKCLMSRDRFLKMRGMEILGNLCKA EDNGVLICEYVDQDSYREIICHLTLPDVLLVTSTLEVLYMLTEMGDIACTKIAKVEKSIDMLVCLVSMDIQMFGPDALAAVKLVEHPSSSHQVLSEMRPQAIEQVQTQSHGAPGPACRAVVAQHAAPP PGIVEIDSEKFACQWLNAHFEVNPDCSVSRAEMYSEYLSTCSKLARGGILTSTGFYKCLRTVFPNHTVKRVEDSSSSGQAHIHVIGVRRRALPLPIQMYYQQQPVSTPVVRVDAVADVSPTPSPAGIP HGSQAVGNHFQRTPVTNQSSNLTATQMSFPVQGVHTVAQTVSRIPPNPSVHTHQQQNSPVTVIQNKAPIPCEVVKATVIQNSVPQTAVPVSIAVGGPAQSSLAQNHSAGPQPVTVVNSQTLLHHPSVM PQPSPLHTVVPGQIPSGTPVTVIQQTVPQSHIFGRVQNIPACTSTVSQGQQLITTSPQPMHTSSQQTAAGSQPQDTVIIAPPQYVTTSASSIVSATSVQNFQVATGQVVTIAGVPSPQPSRVGFQNIA PKPLPSQHVSSTVVQQPVQQPQQPAQQSVVIVSQPAQQGQTYAPAIHQIVLANPAALPTGQTVQLTGQPNITPSSSPSPVPATSNQVPAAMSSSSTLQSQGPPPTVSQMLSVKRQQQQQHSPAAPAQQ VQVQVQPPQVQVQVQPQQAGAGVGQPASSESSLIKQLLLPKRGPSTPGGKLILPAPQIPPPNNARAPSPQVVYQVANSQAAGFGAQGQTPAQQLLVGQPNVQLVQSAMPPTGGVQTVPISNLQILPGP LISNSPATIFQGTSGNQVTITVVPNTSFATATVSQGNAAQLIAPAGISMSGAQAGAGLQVQTLPAGQSACTSAAPPFKGDKIICQKEEEAKEATGLHVHERKIEVMENPSCRRGTTNTSNGDTSESET QVGSLLNGRKYSDSSLPPSHSGKLQSEPNPCSPLSNGPSLELGENGASGKQNSEPVDMQDVKSDLKKTLVNGICDFDKGDGSHLSKNIPNHKTCNHVGNGEVSPVEPQGTLGATQQETAKGDQLERVP NGPALTLGGSPATSSVQEASSVATQPFSGTDLPNGPLASGLTSDVPHQRPSVVVSPRPTAPVIQGHPVIAAPHSGSRGPASALSSDARSTNGTAECKTVKRPAEDGDREAAPGIPNKVGVRIVTISDP NNAGCSATMVAVPAGADPSTVAKVAIGSAAQQKPPPPPAYAQSALPQNTPMPPSPAVQVQGQPSSSQPSPVSASSQHADPVRKPGQNFMCLWQSCKKWFQTPSQVFYHAATEHGGKDVYPGQCLWEGC EPFQRQRFSFITHLQDKHCSKDALLAGLKQDEPGQAANQKSSTKQPTVGSTGSAPRAQKAIASHPSAALMALRRGSRNLVFRDFTDEKEGPITKHIRLTAALILKNIGKYSECGRRLLKRHENNLSVL AISNMEASSTLAKCLYELNFTVQSKEQEQDSEML
hide sequence
Ensembl Acc Id:
ENSRNOP00000006970 ⟸ ENSRNOT00000006970
RefSeq Acc Id:
XP_063120426 ⟸ XM_063264356
- Peptide Label:
isoform X2
- UniProtKB:
A6KC19 (UniProtKB/TrEMBL)
RGD ID: 13695617
Promoter ID: EPDNEW_R6132
Type: initiation region
Name: Arid2_1
Description: AT-rich interaction domain 2
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 7 137,680,606 - 137,680,666 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2015-11-25
Arid2
AT-rich interaction domain 2
Arid2
AT rich interactive domain 2 (Arid-rfx like)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Arid2
AT rich interactive domain 2 (Arid-rfx like)
Arid2_predicted
AT rich interactive domain 2 (Arid-rfx like) (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Arid2_predicted
AT rich interactive domain 2 (Arid-rfx like) (predicted)
Symbol and Name status set to approved
70820
APPROVED